Primary Care
Wegovy Samples for Healthcare Providers
Explore medication sample resources and treatment access support for clinicians prescribing Wegovy® (semaglutide injection or tablets).
Wegovy® (semaglutide injection or) is a GLP-1 receptor agonist indicated for chronic weight management in appropriate patients when used alongside a reduced-calorie diet and increased physical activity. It is administered as a once-weekly subcutaneous injection and may be prescribed to support long-term weight management goals. Wegovy® is commonly used as part of a comprehensive obesity management strategy.
Built to help reduce friction around treatment access & patient care.
Request Wegovy® (semaglutide injection or tablets) sample support and treatment access assistance through DocUpdate Concierge.
Request Samples Through DocUpdate
DocUpdate provides free HIPAA-compliant mobile tools that move care forward.
Frequently Asked Questions About Wegovy Samples
Healthcare providers can download the DocUpdate app and submit a request through Concierge for medication sample and treatment access support.
Wegovy is a once-weekly injectable semaglutide GLP-1 receptor agonist used for chronic weight management and selected cardiovascular risk reduction.
Wegovy may be prescribed for chronic weight management in eligible patients and to reduce certain cardiovascular risks in adults with established cardiovascular disease and obesity or overweight.
DocUpdate is designed for licensed healthcare providers with an active NPI number, including physicians, nurse practitioners, and physician assistants.
No. DocUpdate does not dispense medications or provide direct medication fulfillment. The platform helps healthcare providers navigate medication sample support and treatment access resources through Concierge.
Yes. DocUpdate provides free HIPAA-compliant tools and support resources for healthcare providers.